secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-08-23T23:59:59+00:00
Accession:  0001493152-24-033729
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq notice for late 10-Q filing; must file delinquent reports by Oct 14
--------------------------------------------------------------------------------

- Received Nasdaq notice on Aug 19, 2024 for failure to file Q2 2024 Form 10-Q on time.
- Must submit compliance plan by Sept 3, 2024; all delinquent reports due by Oct 14, 2024.
- Delinquent reports include Q1 2024 10-Q, Q2 2024 10-Q, and 2023 10-K.
- No immediate effect on listing, but further delays risk delisting.
- Company states it intends to file as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224033729/0001493152-24-033729-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224033729/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033729

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer